Drugs that work on the hematologic system play an important role in helping to limit the morbidity and mortality that can be associated with an acute coronary syndrome. The pharmacology of the fibrinolytic agents, thrombin inhibitors, and antiplatelet agents is described. A case study of a woman having an ST-segment elevation myocardial infarction is reviewed to highlight the importance of drugs that work on the hematologic system.
Skip Nav Destination
Hematology| December 01 2012
Clots Kill: Hematologic Pharmacology for ST-Segment Elevation Myocardial Infarction
Stacy H. James, RN, MSN, ACNP, CCRN-CMC
Stacy H. James is a cardiology acute care nurse practitioner at Queen of the Valley Medical Center in Napa, California.
Corresponding author: Stacy H. James, rn, msn, acnp, ccrn-cmc, Queen of the Valley Medical Center, 1000 Trancas Street, Napa, CA 94558 (e-mail: firstname.lastname@example.org).
Search for other works by this author on:
Crit Care Nurse (2012) 32 (6): 35–41.
- Views Icon Views
- Share Icon Share
Stacy H. James; Clots Kill: Hematologic Pharmacology for ST-Segment Elevation Myocardial Infarction. Crit Care Nurse 1 December 2012; 32 (6): 35–41. doi: https://doi.org/10.4037/ccn2012104
Download citation file: